Literature DB >> 3376748

Visual evoked potentials in diabetes mellitus.

K Yaltkaya1, S Balkan, A I Baysal.   

Abstract

25 diabetic patients have been studied in order to investigate the possible effects of the disease on the central nervous system by means of pattern shift visual evoked potentials. Patients with diabetic retinopathy, glaucoma and cataract were excluded from the study. Results obtained from a control group of 30 normal subjects were compared to those of the patient group in which sural nerve conduction velocities have also been determined to see whether there is a correlation between peripheral and central involvement of the nervous system. In diabetic patients latency prolongation in the P100 and N140 components were observed. The N90-N140 interpeak latency was also prolonged. In addition, in patients with longstanding diabetes mellitus the incidence of VEP abnormalities was found to be high. Pathologic changes in VEP latencies did not show any correlation with sural nerve conduction abnormalities.

Entities:  

Mesh:

Year:  1988        PMID: 3376748     DOI: 10.1111/j.1600-0404.1988.tb05902.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Diabetic Retinopathy Analysis.

Authors:  R Sivakumar; G Ravindran; M Muthayya; S Lakshminarayanan; C U Velmurughendran
Journal:  J Biomed Biotechnol       Date:  2005

2.  Changes in frequency-doubling perimetry in patients with type I diabetes prior to retinopathy.

Authors:  Isabel Pinilla; Antonio Ferreras; Miriam Idoipe; Ana I Sanchez-Cano; Diana Perez-Garcia; Laura X Herrera; Maria J Pinilla; Emilio Abecia
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

3.  Pattern Visual Evoked Potentials in Patients with Type II Diabetes Mellitus.

Authors:  Javad Heravian; Akram Ehyaei; Nasser Shoeibi; Abbass Azimi; Hadi Ostadi-Moghaddam; Abbas-Ali Yekta; Mohamad Javad Khoshsima; Habbibolah Esmaily
Journal:  J Ophthalmic Vis Res       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.